David M. Kunis

1.9k total citations
23 papers, 1.6k citations indexed

About

David M. Kunis is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, David M. Kunis has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in David M. Kunis's work include Neuroscience and Neuropharmacology Research (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Neurological Disease Mechanisms and Treatments (5 papers). David M. Kunis is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Neurological Disease Mechanisms and Treatments (5 papers). David M. Kunis collaborates with scholars based in United States and India. David M. Kunis's co-authors include Gary K. Steinberg, Guo Hua Sun, Midori A. Yenari, Bruce R. Ransom, Dora Y. Ho, Robert M. Sapolsky, David J. Onley, Carolina M. Maier, Robert L. DeLaPaz and J. William Langston and has published in prestigious journals such as Science, Stroke and Annals of Neurology.

In The Last Decade

David M. Kunis

23 papers receiving 1.6k citations

Peers

David M. Kunis
Guo Hua Sun United States
Robert M. Brucklacher United States
Keri J Hopkins United States
Bingren Hu United States
William C. Taft United States
Michael Jacewicz United States
Ashley K. Pringle United Kingdom
Guo Hua Sun United States
David M. Kunis
Citations per year, relative to David M. Kunis David M. Kunis (= 1×) peers Guo Hua Sun

Countries citing papers authored by David M. Kunis

Since Specialization
Citations

This map shows the geographic impact of David M. Kunis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Kunis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Kunis more than expected).

Fields of papers citing papers by David M. Kunis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Kunis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Kunis. The network helps show where David M. Kunis may publish in the future.

Co-authorship network of co-authors of David M. Kunis

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Kunis. A scholar is included among the top collaborators of David M. Kunis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Kunis. David M. Kunis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yenari, Midori A., Guo Hua Sun, David M. Kunis, David J. Onley, & Vladimir Vexler. (2001). L-selectin inhibition does not reduce injury in a rabbit model of transient focal cerebral ischemia. Neurological Research. 23(1). 72–78. 30 indexed citations
2.
Phillips, Russell G., Michelle Monje, Timothy J. Meier, et al.. (2001). Gene therapy effectiveness differs for neuronal survival and behavioral performance. Gene Therapy. 8(8). 579–585. 13 indexed citations
3.
Maier, Carolina M., Guo Hua Sun, David M. Kunis, Midori A. Yenari, & Gary K. Steinberg. (2001). Delayed induction and long-term effects of mild hypothermia in a focal model of transient cerebral ischemia: neurological outcome and infarct size. Journal of neurosurgery. 94(1). 90–96. 153 indexed citations
4.
Yenari, Midori A., Masabumi Minami, Guo Hua Sun, et al.. (2001). Calbindin D28K Overexpression Protects Striatal Neurons From Transient Focal Cerebral Ischemia. Stroke. 32(4). 1028–1035. 104 indexed citations
5.
Yenari, Midori A., Christian Beaulieu, Guo Hua Sun, et al.. (1998). Thrombolysis with reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke. Journal of Stroke and Cerebrovascular Diseases. 7(3). 179–186. 9 indexed citations
6.
Yenari, Midori A., Sheri Fink, Guo Hua Sun, et al.. (1998). Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Annals of Neurology. 44(4). 584–591. 285 indexed citations
7.
Yenari, Midori A., David M. Kunis, Guo Hua Sun, et al.. (1998). Hu23F2G, an Antibody Recognizing the Leukocyte CD11/CD18 Integrin, Reduces Injury in a Rabbit Model of Transient Focal Cerebral Ischemia. Experimental Neurology. 153(2). 223–233. 98 indexed citations
8.
Pérez‐Pinzón, Miguel A., et al.. (1997). SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits. Journal of the Neurological Sciences. 153(1). 25–31. 54 indexed citations
9.
Lawrence, Matthew S., Dora Y. Ho, Laura J. McIntosh, et al.. (1997). Herpes Simplex Viral Vectors Expressing Bcl-2 Are Neuroprotective When Delivered After a Stroke. Journal of Cerebral Blood Flow & Metabolism. 17(7). 740–744. 123 indexed citations
10.
Young, Stuart W., Qing Fan, David M. Kunis, & Gary K. Steinberg. (1996). Experimental Acute Cerebral Ischemia with Reperfusion. Investigative Radiology. 31(6). 353–358. 8 indexed citations
11.
Lawrence, Matthew S., Guo Hua Sun, David M. Kunis, et al.. (1996). Overexpression of the Glucose Transporter Gene with a Herpes Simplex Viral Vector Protects Striatal Neurons against Stroke. Journal of Cerebral Blood Flow & Metabolism. 16(2). 181–185. 81 indexed citations
12.
Steinberg, Gary K., et al.. (1995). Neuroprotection by N-methyl-d-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing. Neuroscience. 64(1). 99–107. 16 indexed citations
13.
Maier, Carolina M., Guo Hua Sun, David M. Kunis, Rona G. Giffard, & Gary K. Steinberg. (1995). Neuroprotection by the N‐Methyl‐d‐Aspartate Receptor Antagonist CGP 40116: In Vivo and In Vitro Studies. Journal of Neurochemistry. 65(2). 652–659. 27 indexed citations
14.
Steinberg, Gary K., Nariman Panahian, Guo-Hua Sun, Carolina M. Maier, & David M. Kunis. (1994). Cerebral damage caused by interrupted, repeated arterial occlusion versus uninterrupted occlusion in a focal ischemic model. Journal of neurosurgery. 81(4). 554–559. 27 indexed citations
15.
Steinberg, Gary K., et al.. (1993). Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile. Neurological Research. 15(3). 174–180. 41 indexed citations
16.
Steinberg, Gary K., et al.. (1991). Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia. Neuroscience Letters. 133(2). 225–228. 28 indexed citations
17.
Steinberg, Gary K., et al.. (1991). Protection after Transient Focal Cerebral Ischemia by theN-Methyl-d-Aspartate Antagonist Dextrorphan is Dependent upon Plasma and Brain Levels. Journal of Cerebral Blood Flow & Metabolism. 11(6). 1015–1024. 27 indexed citations
18.
Steinberg, Gary K., et al.. (1989). Pretreatment with the NMDA antagonist dextrorphan reduces cerebral injury following transient focal ischemia in rabbits. Brain Research. 497(2). 382–386. 21 indexed citations
19.
Steinberg, Gary K., et al.. (1988). Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia. Neuroscience Letters. 89(2). 193–197. 85 indexed citations
20.
Serrano, Elba E., David M. Kunis, & Bruce R. Ransom. (1988). Effects of chronic phenobarbital exposure on cultured mouse spinal cord neurons. Annals of Neurology. 24(3). 429–438. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026